Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.

ABSTRACT:

Introduction

COVID-19 is an acute respiratory viral infection that threatens people worldwide, including people with rheumatic disease, although it remains unclear to what extent various antirheumatic disease therapies increase susceptibility to complications of viral respiratory infections.

Objective

The present study undertakes a scoping review of available evidence regarding the frequency and severity of acute respiratory viral adverse events related to antirheumatic disease therapies.

Methods

Online databases were used to identify, since database inception, studies reporting primary data on acute respiratory viral infections in patients utilizing antirheumatic disease therapies. Independent reviewer pairs charted data from eligible studies using a standardized dat

SUBMITTER: Kilian A 

PROVIDER: S-EPMC7832282 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature